Topics

US Appeal Against 2021 Cabazitaxel Patent Falls Flat

02:42 EDT 15 Aug 2019 | SCRIP

An attempt by Accord, Actavis, Apotex, Kabi and Mylan to overturn a US patent protecting Sanofi’s Jevtana cabazitaxel cancer drug...

      

Related Stories

 

Original Article: US Appeal Against 2021 Cabazitaxel Patent Falls Flat

NEXT ARTICLE

More From BioPortfolio on "US Appeal Against 2021 Cabazitaxel Patent Falls Flat"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...